|
US6630507B1
(en)
|
1998-04-21 |
2003-10-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cannabinoids as antioxidants and neuroprotectants
|
|
US6566560B2
(en)
|
1999-03-22 |
2003-05-20 |
Immugen Pharmaceuticals, Inc. |
Resorcinolic compounds
|
|
AU3910700A
(en)
|
1999-03-22 |
2000-10-09 |
Immugen Pharmaceuticals, Inc. |
Treatment of immune diseases
|
|
NZ525243A
(en)
|
2000-10-31 |
2005-01-28 |
Pharma Mar S |
A lyophilised formulation comprising kahalalide F, a peptide isolated from a herbivorous marine species of mollusc, Elysia rufescens, to treat cancer
|
|
EP1206934A1
(en)
*
|
2000-11-15 |
2002-05-22 |
B. Braun Melsungen Ag |
Blockade of sodium channels by phenol derivatives
|
|
US10004684B2
(en)
|
2001-02-14 |
2018-06-26 |
Gw Pharma Limited |
Pharmaceutical formulations
|
|
EP1482917B1
(en)
*
|
2002-02-01 |
2019-05-08 |
GW Pharma Limited |
Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions
|
|
GB0202385D0
(en)
*
|
2002-02-01 |
2002-03-20 |
Gw Pharma Ltd |
Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
|
|
IL148244A0
(en)
|
2002-02-19 |
2002-09-12 |
Yissum Res Dev Co |
Anti-nausea and anti-vomiting activity of cannabidiol compounds
|
|
WO2003075917A1
(en)
|
2002-03-08 |
2003-09-18 |
Signal Pharmaceuticals, Inc. |
Combination therapy for treating, preventing or managing proliferative disorders and cancers
|
|
ATE533472T1
(de)
*
|
2002-08-14 |
2011-12-15 |
Gw Pharma Ltd |
Flüssige cannabinoid-formulierungen zur verabreichung an die schleimhäute
|
|
US7067155B2
(en)
*
|
2003-01-03 |
2006-06-27 |
Tbni, Inc. |
Anti-inflammatory humate compositions and methods of use thereof
|
|
IL160420A0
(en)
*
|
2004-02-16 |
2004-07-25 |
Yissum Res Dev Co |
Treating or preventing diabetes with cannabidiol
|
|
WO2006024958A2
(en)
*
|
2004-08-09 |
2006-03-09 |
Novimmune S.A. |
Cannabinoid compositions and methods of use thereof
|
|
US8911751B2
(en)
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
|
US20100158973A1
(en)
|
2006-03-13 |
2010-06-24 |
Hadasit Medical Research Services & Development Llimited |
Therapeutic uses of cannabidiol compounds
|
|
GB2438682A
(en)
*
|
2006-06-01 |
2007-12-05 |
Gw Pharma Ltd |
New use for cannabinoids
|
|
GB2448535A
(en)
*
|
2007-04-19 |
2008-10-22 |
Gw Pharma Ltd |
New use for cannabinoid-containing plant extracts
|
|
GB2450741A
(en)
*
|
2007-07-05 |
2009-01-07 |
Gw Pharma Ltd |
Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease
|
|
ES2359168T3
(es)
*
|
2007-10-02 |
2011-05-19 |
Vivacell Biotechnology España S.L. |
Composición que comprende cannabinoides no psicotrópicos para el tratamiento de enfermedades antiinflamatorias.
|
|
GB2496688B
(en)
|
2011-11-21 |
2016-06-29 |
Gw Pharma Ltd |
Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases
|
|
US9889100B2
(en)
|
2013-05-02 |
2018-02-13 |
Mor Research Applications Ltd. |
Cannabidiol for treatment of severe and refractory graft-versus-host disease
|
|
US9956182B2
(en)
|
2013-05-02 |
2018-05-01 |
Mor Research Applications Ltd. |
Cannabidiol for the prevention and treatment of graft-versus-host disease
|
|
US10172786B2
(en)
*
|
2014-12-16 |
2019-01-08 |
Axim Biotechnologies, Inc. |
Oral care composition comprising cannabinoids
|
|
US10960035B2
(en)
|
2015-04-01 |
2021-03-30 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
|
US12303541B2
(en)
|
2015-04-01 |
2025-05-20 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
US20180296521A1
(en)
*
|
2015-10-16 |
2018-10-18 |
Scythian Biosciences Inc. |
Methods and compositions for treating gastrointestinal inflammation
|
|
WO2017160923A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Royal Oil Colorado Llc |
Formulations of argan oil and cannabidiol
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
US10399920B2
(en)
|
2016-06-01 |
2019-09-03 |
S&B Pharma, Inc. |
Crystalline form of cannabidiol
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551985B
(en)
*
|
2016-07-01 |
2019-01-30 |
Gw Res Ltd |
Novel formulation
|
|
CA3077624A1
(en)
|
2016-10-01 |
2018-04-05 |
James Smeeding |
Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof
|
|
EP3534893A1
(en)
|
2016-11-02 |
2019-09-11 |
To Pharmaceuticals LLC |
Combination therapy of cbd and copaxone
|
|
EP3592346A4
(en)
|
2017-03-05 |
2020-12-30 |
The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
|
JP6893012B2
(ja)
*
|
2017-07-18 |
2021-06-23 |
徳義制薬有限公司Ｄｅｙｉ Ｐｈａｒｍａｒｍａｃｅｕｔｉｃａｌ Ｌｔｄ． |
肺高血圧症の治療におけるカンナビジオールの応用
|
|
JP2020530857A
(ja)
*
|
2017-08-14 |
2020-10-29 |
ジナーバ・ファーマシューティカルズ・インコーポレイテッド |
経皮カンナビジオールゲルを用いた変形性関節症の治療方法
|
|
US10945982B1
(en)
*
|
2018-05-03 |
2021-03-16 |
Paul A. Lobel |
Nasal hygiene method and composition
|
|
US11110056B1
(en)
|
2018-05-03 |
2021-09-07 |
Actual Natural Health & Wellness Products, Inc. |
Nasal hygiene method and composition
|
|
EP3801028A4
(en)
|
2018-05-30 |
2022-04-13 |
Direct Biologics LLC |
A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
|
|
WO2020081513A1
(en)
*
|
2018-10-16 |
2020-04-23 |
Systamedic Inc. |
Novel compositions for the treatment of inflammatory diseases
|
|
US11026888B1
(en)
|
2019-01-04 |
2021-06-08 |
Nutrition Therapeutics, Inc. |
Functional beverage compositions and methods of using and making same
|
|
AU2019424226B2
(en)
*
|
2019-01-24 |
2023-06-29 |
Hanyi Bio-Technology Company Ltd. |
Use of geranylflavone A in preparation of drug for promoting healing of wounds
|
|
US12569517B2
(en)
|
2019-02-07 |
2026-03-10 |
Direct Biologics, Llc |
Method for treating osteoarthritis with mesenchymal stem cell exosomes
|
|
EP3923915A4
(en)
*
|
2019-02-11 |
2023-03-22 |
John Robert Chancey |
METHODS OF PREPARATION AND USE OF PHYTOCANNABINOIDS IN A COMPLEX WITH A PROTEIN, PEPTIDE, AMINO ACID, POLYSACCHARIDE, DISACCHARIDE OR MONOSACCHARIDE
|
|
WO2020223510A1
(en)
*
|
2019-04-30 |
2020-11-05 |
Greenway Herbal Products, Llc |
Cannabinoid compositions and methods of using
|
|
US12213995B2
(en)
|
2019-07-18 |
2025-02-04 |
Direct Biologics, Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
US20230128114A1
(en)
*
|
2020-04-02 |
2023-04-27 |
Incannex Healthcare Limited |
Methods and compositions for treating or preventing an inflammatory condition
|
|
KR20230004709A
(ko)
|
2020-04-22 |
2023-01-06 |
다이렉트 바이오로직스 엘엘씨 |
감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
|
|
CA3182152A1
(en)
*
|
2020-05-11 |
2021-11-18 |
Add Advanced Drug Delivery Technologies Ltd. |
Uses and formulations of cannabinoids
|
|
US20230201284A1
(en)
*
|
2020-05-11 |
2023-06-29 |
Add Advanced Drug Delivery Technologies Ltd. |
Uses and Formulations of Cannabinoids
|
|
AU2021386606A1
(en)
|
2020-11-24 |
2023-06-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Cannabinoid derivatives and their use for the treatment of inflammation and/or pain and/or obesity
|
|
US20240325312A1
(en)
*
|
2021-07-15 |
2024-10-03 |
Incannex Healthcare Limited |
Composition comprising cannabidiol and hydroxychloroquine in a fixed dose combination capsule
|
|
EP4436559A4
(en)
*
|
2021-11-27 |
2025-04-02 |
Miralogx LLC |
SYNTHETIC CANNABINOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT
|
|
EP4230201A1
(en)
|
2022-02-21 |
2023-08-23 |
Universidade Nova De Lisboa |
Composition for treating neurodegenerative diseases
|
|
CA3244798A1
(en)
|
2022-02-21 |
2023-08-24 |
Universidade Nova De Lisboa |
COMPOUNDS AND COMPOSITIONS AGAINST NEURODEGENERATIVE DISEASES
|
|
AU2023321655A1
(en)
|
2022-08-12 |
2025-02-13 |
Jazz Pharmaceuticals Research Uk Limited |
Oral solid dosage forms comprising cannabinoids
|
|
US12502407B2
(en)
|
2024-04-25 |
2025-12-23 |
Direct Biologics, Llc |
Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
|
|
WO2025259202A1
(en)
*
|
2024-06-12 |
2025-12-18 |
Chiang Mai University |
A method of reprogramming human somatic cells and reprogrammed cells derived thereof
|